| NCT ID | NCT07311044 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Pulmonary Hypertension |
| Study Type | OBSERVATIONAL |
| Enrollment | 7,000 participants |
| Start Date | 2021-01-08 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 7,000 participants in total. It began in 2021-01-08 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to determine the association between patient voice signal characteristics and the presence and severity of pulmonary hypertension in patients referred for elective clinically indicated echocardiography for at Mayo Clinic MN.
Eligibility Criteria
Inclusion Criteria: * All individuals who present for a routine elective, clinically indicated, diagnostic echocardiogram at the echocardiography laboratory at Mayo Clinic * All individuals who have had a clinically indicated, diagnostic echocardiogram at the echocardiography lab at Mayo Clinic before a scheduled procedure in the cardiac catheterization lab at Mayo Clinic * All individuals who have had a clinically indicated diagnostic echocardiogram at the echocardiography lab at Mayo Clinic and have an appointment in any CV outpatient clinic. Exclusion Criteria: * Known history of voice disorder either primary or secondary to neuromuscular or other pathology * Patients under the age of 18 years
Contact & Investigator
Amir Lerman, M.D.
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07311044 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07311044 currently recruiting?
Yes, NCT07311044 is actively recruiting participants. Contact the research team at albers.diana2@mayo.edu for enrollment information.
Where is the NCT07311044 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07311044 clinical trial?
NCT07311044 is sponsored by Mayo Clinic. The principal investigator is Amir Lerman, M.D. at Mayo Clinic. The trial plans to enroll 7,000 participants.